Brian M. Culley

2022 - BioTime

In 2022, Brian M. Culley earned a total compensation of $2.4M as Chief Executive Officer at BioTime, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$319,900
Option Awards$1,159,875
Salary$609,000
Stock Awards$268,503
Other$15,250
Total$2,372,528

Culley received $1.2M in option awards, accounting for 49% of the total pay in 2022.

Culley also received $319.9K in non-equity incentive plan, $609K in salary, $268.5K in stock awards and $15.3K in other compensation.

Rankings

In 2022, Brian M. Culley's compensation ranked 1,525th out of 5,676 executives tracked by ExecPay. In other words, Culley earned more than 73.1% of executives.

ClassificationRankingPercentile
All
1,525
out of 5,676
73rd
Division
Manufacturing
771
out of 3,084
75th
Major group
Chemicals And Allied Products
301
out of 1,399
79th
Industry group
Drugs
279
out of 1,300
79th
Industry
Biological Products, Except Diagnostic Substances
72
out of 295
76th
Source: SEC filing on July 27, 2023.

Culley's colleagues

We found three more compensation records of executives who worked with Brian M. Culley at BioTime in 2022.

2022

Kevin Cook

BioTime

Chief Financial Officer

2022

George Samuel

BioTime

General Counsel

2022

Jill Howe

BioTime

Chief Financial Officer

News

You may also like